The role of glucocorticoids in body fluid control is full of controversy. It is well documented that glucocorticoids could produce potent and persistent diuresis in congestive heart failure. But, the diuretic effect was not reported in patients with euvolemia. Objective: To test the hypothesis that the diuresis induced by glucocorticoids is systemic volume dependent. Methods: The diuretic effect of glucocorticoids in rats with various systemic volume statuses (i.e. systemic volume depletion, euvolemia, and systemic volume overload, respectively) was recorded. Results: glucocorticoids only produced potent and persistent diuresis in the rats with systemic volume overload.
Every disturbance in the body evokes a stress response that serves to restore homeostasis. When exposing to stress, the hypothalamic-pituitary-adrenal system involving corticosteroid hormone secreted by the adrenals plays a crucial role in restoring homeostasis. It is well documented that hypothalamus plays a fundamental role in the body fluid control by secreting vasopressin and oxytocin in response to osmotic/nonosmotic stimuli. Newly emerged evidence showed that corticosteroid hormone also provided a potent defense mechanism against volume overload in mammals (1) . The role of glucocorticoids in body fluid and sodium metabolism is full of controversy. Traditional teaching dedicates that glucocorticoids cause hypertension as a consequence of sodium and water retention (2) . But, newly emerged evidence demonstrated that the rise in blood pressure is very likely due to the increased pressor responsiveness induced by glucocorticoids (3) (4) (5) (6) (7) (8) . Long term glucocorticoid exposure did not increase the occurrence of heart failure in large cohort studies (9, 10). A meta-analysis involving 3,793 patients showed that corticosteroid treatment may be beneficial in acute myocardial infarction (11). Mover over, contrary to the notion that glucocorticoids cause renal water and sodium retention, plenty of evidence showed acute glucocorticoid administration could produce potent diuresis and natriuresis in rats (1, 8, 12, 13) . In clinical observation, chronic glucocorticoid administration could produce potent diuresis and restore body fluid homeostasis in heart failure patients with severe fluid overload (14-17). However, there was no report that long term glucocorticoid treatment caused potent diuresis in the subjects other than heart failure with fluid overload (9-11). What is the mechanism underlying this paradoxical phenomenon? Recently, it is revealed that the glucocorticoids can act centrally, as well as peripherally, to assist in the normalization of extracellular fluid volume. The data showed that glucocorticoids not only produced potent diuretic effect, but inhibited dehydration-induced water intake and sodium depletion-induced sodium intake by upregulating the expression of natriuretic peptide receptor A (NPR-A) in the kidney and hypothalamus, resulted in overt volume depletion (1, 18, 19) . Thus, it is reasonable to assume that the diuresis induced by glucocorticoids is systemic volume dependent, i.e. the diuresis only appears when the patent is under fluid overload status. To elucidate the precise mechanism, we designed this study.
Materials and methods
Three models with different systemic volume statuses were established, i.e. systemic volume depletion model, normal systemic volume model and systemic volume overload model, respectively. The rats of three models were randomized to receive dexamethasone sodium phosphate (Dex, 1mg/kg) or vehicle. The urinary volumes were monitored during the study period. All animals were managed in accordance with the guidelines of the Hebei Medical University, and the position of the American Heart Association on Research Animal Use. Experimental protocol was approved by the Institutional Animal Care and Use Committee of Hebei Medical University.
Systemic volume depletion model
Twenty intact Wistar rats were deprived of water to have their systemic volume depleted.
Normal systemic volume model
Twenty intact Wistar rats had free access to water and food to have euvolemia.
Systemic volume overload model
The post-infarction rat model of heart failure used in the study was prepared by the standard method previously prescribed (20). The survived rats were raised for 12 weeks to have decompensated heart failure (i.e. heart failure with fluid overload) (20, 21).
Statistical analysis
All the data were express as means ± standard error of mean (s.e.m).
Results
The data showed that the diuretic effect of Dex was more persistent in the systemic volume overload status compared with those rats with systemic volume depletion or euvolemia. The diuretic effect of one dose of Dex peaked at 6 hours after Dex treatment in water deprived rats and lasted only 12 hours, whereas it peaked at 18 hours and lasted for as much as 45 hours in rats with systemic volume overload. The diuretic effect induced by Dex in the rats with normal hydration was in between (Fig 1A, B, and C) .
Discussion
The data presented in the paper showed that the diuresis induced by glucocorticoids was systemic volume dependent, i.e. glucocorticoids only produced potent and persistent diuresis in the subjects with systemic volume overload. The published data about glucocorticoids in body fluid metabolism have been confusing. Plenty of evidence showed that glucocorticoids could produce potent diuretic effect in patients with congestive heart failure (14-17); whereas large cohort studies did not document this effect in the patients without heart failure (9-11). Our finding, i.e. the diuresis induced by glucocorticoids is systemic volume dependent, provided an answer for the confusing data. 
The role of glucocorticoids in body fluid control
The diuresis induced by glucocorticoids is systemic volume dependent because they can centrally inhibit water drinking and salt appetite. Since the discovery of atrial natriuretic peptide (ANP), a peptide hormone secreted by the atrial myocytes in response to volume expansion, the vital role of ANP and its analogs in body fluid control is well recognized. They provided a potent mechanism counterbalancing the salt-and water-retaining actions of the renin-angiotensin-aldosterone system in mammals. ANP is localized mostly in the heart, but ANP and NPR-A, are also found in the kidney and hypothalamic areas involved in body fluid volume control. Blood volume expansion acts not only directly on the heart, by stretch of atrial myocytes to increase the release of ANP, but also on the brain ANPergic neurons through afferent inputs from baroreceptors. Renal NPR-A activation induces potent diuresis and natriuresis, whereas hypothalamic NPR-A activation produces potent inhibitory effects on water drinking (22-24). They work in concert to prevent the body from fluid overload. Our recent findings showed that glucocorticoids could upregulate NPR-A expression in the hypothalamus and kidney (1, 18) . Consequently, glucocorticoids could produce potent diuresis while dramatically inhibiting water drinking and salt intake (1, 19) . In rats given ad libitum access to water and food, glucocorticoids, such as Dex, can greatly increase urinary excretion of water without compensatory increases in water drinking, leading to systemic volume depletion (1, 12) . The central inhibitory effects on water and sodium intake have the body under status of systemic volume depletion. Systemic volume depletion, in turn, compromises the subsequent renal water and sodium excretion. This is the mechanism that diuresis induced by glucocorticoids is systemic volume dependent. In conclusion, consistent with ANP's physiological role in body fluid metabolism, glucocorticoids play a crucial role in fluid volume control not only by blocking the neurogenic mechanisms responsible for the stimulation of water intake, but also by stimulating potent diuretic action through activating renal natriuretic peptide system in the kidney. 
